Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma

Thyroid

Volumn 20, Issue 1, 2010, Pages 93-98

  Borschitz, Thomas ^a   Eichhorn, Waltraud ^b   Fottner, Christian ^a   Hansen, Torsten ^a   Schad, Arno ^a   Schadmand Fischer, Simin ^a   Weber, Matthias M ^a   Schreckenberger, Mathias ^b   Lang, Hauke ^a   Musholt, Thomas J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Nuclear Medicine ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; LEVOTHYROXINE; PROTEIN RET; RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; ARTICLE; CANCER SURVIVAL; CASE REPORT; DISTANT METASTASIS; FEMALE; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; OCCULT CANCER; PANCREATIC METASTASES; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; THYROID PAPILLARY CARCINOMA; TISSUE SECTION;

ADULT; CARCINOMA, PAPILLARY; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROTO-ONCOGENE PROTEINS B-RAF; RADIOTHERAPY, ADJUVANT; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 75149198344     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0026     Document Type: Article

References (31)

1. Albores-Saaverda J, Gould E, Vardaman C, Vuitch F 1991 The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 22:1195-1205.
2. LiVolsi VA, Albores-Saavedra J, Asa SL, Baloch ZW, Sobrinho-Simoes M, Wenig B, DeLellis RA, Cady B 2004 Papillary carcinoma (World Health Organization classification of tumors). In: De Lellis RA, Lloyd RV, Heitz PU, Eng C (eds) Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon, France, pp. 57-66.
3. Yuksel O, Kurukahvecioglu O, Ege B, Ekinci O, Aydin A, Poyraz A, Tezel E, Taneri F 2008 The relation between pure papillary and follicular variant in papillary thyroid carcinoma. Endocr Regul 42:29-33.
4. Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M 2008 Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15: 1518-1522.
5. Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, Michels JJ, Reznik Y, Henry-Amar M 2008 Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 158:551-560.
6. Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW, Chen JY, Li KL, Chen JF, Ho YS 1999 Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 9:1227-1235.
7. Haigh PI, Urbach DR, Rotstein LE 2005 Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer. Ann Surg Oncol 12:81-89.
8. Kim S, Wei JP, Braveman JM, Brams DM 2004 Predicting outcome and directing therapy for papillary thyroid carcinoma. Arch Surg 139:390-394.
9. Surveillance, Epidemiology, and End Results Program (www.seer.cancer.gov) . SEER*Stat Database: Incidence-SEER 12 Regs Public-Use, November 2002 Sub (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.
10. Fritz A, Ries L 1998 SEER extent of disease, codes and coding instructions (No.T-899; Pub. No. 98-4354). In: Fritz A, Ries L (eds) The SEER Program Code Manual, 3rd edition. National Cancer Institute, Bethesda, MD, p 7.
11. Panoussopoulos D, Theodoropoulos G, Vlahos K, Lazaris ACh, Papadimitriou K 2007 Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma. Int Surg 92:226-229.
12. Pucci A, Suppo M, Lucchesi G, Celeste A, Viberti L, Pellerito R, Papotti M 2006 Papillary thyroid carcinoma presenting as a solitary soft tissue arm metastasis in an elderly hyperthyroid patient. Case report and review of the literature. Virchows Arch 448:857-861.
13. Brogioni S, Viacava P, Tomisti L, Martino E, Macchia E 2007 A special case of bilateral ovarian metastases in a woman with papillary carcinoma of the thyroid. Exp Clin Endocrinol Diabetes 115:397-400.
14. Sarda AK, Pandey D, Bhalla SA, Goyal A 2004 Isolated submandibular gland metastasis from an occult papillary thyroid cancer. Indian J Cancer 41:89-91.
15. Argibay Vázquez S, Lancha Hernández C, Martínez Muñiz A 2005 Metastases in the sphenoidal sinus in a patient with papillary thyroid cancer. Clin Transl Oncol 7: 324-327.
16. Pazaitou-Panayiotou K, Kaprara A, Chrisoulidou A, Boudina M, Georgiou E, Patakiouta F, Drimonitis A, Vainas I 2005 Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. Endocr J 52:653-657.
17. Imamura Y, Kasahara Y, Fukuda M 2000 Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid. Endocr Pathol 11:97-108. (Pubitemid 30307949)
18. Wagenaar N, Oosterhuis JW, Rozendaal L, Comans E, Simsek S 2008 Adrenal metastasis from a primary papillary thyroid carcinoma. Intern Med 47:2165-2168.
19. Jobran R, Baloch ZW, Aviles V, Rosato EF, Schwartz S, Li-Volsi VA 2000 Tall cell papillary carcinoma of the thyroid: metastatic to the pancreas. Thyroid 10:185-187.
20. Siddiqui AA, Olansky L, Sawh RN, Tierney WM 2006 Pancreatic metastasis of tall cell variant of papillary thyroid carcinoma: diagnosis by endoscopic ultrasound-guided fine needle aspiration. JOP 7:417-422.
21. Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G, Vitale M 2006 Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 154:341-348.
22. Frasca F, Nucera C, Pellegriti G, Gangemi P, Attard M, Stella M, Loda M, Vella V, Giordano C, Trimarchi F, Mazzon E, Belfiore A, Vigneri R 2008 BRAF (V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer 15:191-205.
23. Zgraggen K, Fernandez-del Castillo C, Rattner, DW, Sigala H, Warshaw AL 1998 Metastases to the pancreas and their surgical extirpation. Arch Surg 133:413-417.
24. Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X 2005 Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 103:2261-2268.
25. Imkamp F, von Wasielewski R, Musholt TJ, Musholt PB 2007 Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET=PTC 1-12 transcripts. J Surg Res 143:350-363.
26. Al-Brahim N, Asa SL 2006 Papillary thyroid carcinoma-an overview. Arch Pathol Lab Med 130:1057-1062.
27. Baloch ZW, Livolsi VA 2002 Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143-150.
28. Ruter A, Dreifus J, Jones M, Nishiyama R, Lennquist S 1996 Overexpression of p53 in tall cell variants of papillary thyroid carcinoma. Surgery 120:1046-1050. (Pubitemid 26418785)
29. Xing M 2007 BRAF Mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical Implications. Endocr Rev 28:742-762.
30. Palmedo H, Bucerius J, Joe A, Strunk H, Hortling N, Meyka S, Roedel R, Wolff M, Wardelmann E, Biersack HJ, Jaeger U 2006 Integrated PET=CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 47:616-624.
31. Sugitani I, Fujimoto Y, Yamamoto N 2008 Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143:35-42.